ArticleTranslational and clinical pharmacology2025
Acid-suppressive effect of tegoprazan 12.5 mg BID: a phase 1 comparative study with tegoprazan 25 mg QD and famotidine 20 mg BID.
Ho-Sook Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.